186 related articles for article (PubMed ID: 17880327)
1. Coronary stents, hypersensitivity reactions, and the Kounis syndrome.
Kounis NG; Hahalis G; Theoharides TC
J Interv Cardiol; 2007 Oct; 20(5):314-23. PubMed ID: 17880327
[TBL] [Abstract][Full Text] [Related]
2. Drug-eluting stent thrombosis: the Kounis hypersensitivity-associated acute coronary syndrome revisited.
Chen JP; Hou D; Pendyala L; Goudevenos JA; Kounis NG
JACC Cardiovasc Interv; 2009 Jul; 2(7):583-93. PubMed ID: 19628178
[TBL] [Abstract][Full Text] [Related]
3. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
4. Drug-eluting stent thrombosis.
Steinberg DH; Satler LF
Minerva Cardioangiol; 2008 Feb; 56(1):127-37. PubMed ID: 18432175
[TBL] [Abstract][Full Text] [Related]
5. Kounis syndrome: a manifestation of drug-eluting stent thrombosis associated with allergic reaction to contrast material.
Kogias JS; Papadakis EX; Tsatiris CG; Hahalis G; Kounis GN; Mazarakis A; Batsolaki M; Gouvelou-Deligianni GV; Kounis NG
Int J Cardiol; 2010 Mar; 139(2):206-9. PubMed ID: 18805597
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry.
Sousa A; Costa JR; Moreira AC; Cano M; Maldonado G; Costa RA; Pavanello R; Romano ER; Campos C; Haddad N; Abizaid A; Feres F; Mattos LA; Staico R; Sousa JE;
J Interv Cardiol; 2008 Aug; 21(4):307-14. PubMed ID: 18754966
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting coronary stents: hypersensitivity reactions to paclitaxel. A case report.
Pfoch L; Mahler V; Sticherling M
Dermatology; 2009; 218(1):52-5. PubMed ID: 18987464
[TBL] [Abstract][Full Text] [Related]
8. Drug-eluting coronary stents: hypersensitivity reactions to paclitaxel and the risk of Kounis syndrome.
Soufras GD; Kounis GN; Chiladakis JA; Kounis SA; Gouvelou-Deligianni GV; Batsolaki M; Kounis NG
Dermatology; 2009; 219(1):87-8. PubMed ID: 19246881
[No Abstract] [Full Text] [Related]
9. Hypersensitivity to drug-eluting stent and stent thrombosis: Kounis or not Kounis syndrome?
Tan W; Cheng KL; Chen QX
Chin Med J (Engl); 2009 Oct; 122(19):2390-3. PubMed ID: 20079145
[No Abstract] [Full Text] [Related]
10. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
Bertrand OF; Faurie B; Larose E; Nguyen CM; Gleeton O; Déry JP; Noël B; Proulx G; Roy L; Costerousse O; De Larochellière R; Rodés-Cabau J
J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823
[TBL] [Abstract][Full Text] [Related]
11. Drug eluting stent-induced Kounis syndrome.
Venturini E; Magni L; Kounis NG
Int J Cardiol; 2011 Jan; 146(1):e16-9. PubMed ID: 19174317
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
13. Pathology of drug-eluting stents: implications for coronary intervention.
Finn AV; Nakazawa G; Virmani R
Indian Heart J; 2007; 59(2 Suppl B):B41-9. PubMed ID: 19153436
[TBL] [Abstract][Full Text] [Related]
14. Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model.
Garg P; Cohen DJ; Gaziano T; Mauri L
J Am Coll Cardiol; 2008 May; 51(19):1844-53. PubMed ID: 18466798
[TBL] [Abstract][Full Text] [Related]
15. Drug-eluting stent safety.
Slottow TL; Waksman R
Am J Cardiol; 2007 Oct; 100(8B):10M-17M. PubMed ID: 17950827
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
17. Drug-eluting stent for long coronary artery disease.
Park SJ; Kim YH
Indian Heart J; 2008; 60(6):519-23. PubMed ID: 19276489
[No Abstract] [Full Text] [Related]
18. Antiplatelet therapy following drug-eluting stent implantation: new clinical data and recommendations.
Paradis JM; Ducrocq G; Tanguay JF
Minerva Cardioangiol; 2008 Feb; 56(1):139-54. PubMed ID: 18432176
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.
Nebeker JR; Virmani R; Bennett CL; Hoffman JM; Samore MH; Alvarez J; Davidson CJ; McKoy JM; Raisch DW; Whisenant BK; Yarnold PR; Belknap SM; West DP; Gage JE; Morse RE; Gligoric G; Davidson L; Feldman MD
J Am Coll Cardiol; 2006 Jan; 47(1):175-81. PubMed ID: 16386683
[TBL] [Abstract][Full Text] [Related]
20. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK
J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
